CD274 and cancer: Mittal et al. [57] developed an in silico structure-driven approach to screen and classify small molecules from the Asinex Signature library for the investigation of the inhibition of the PPIs between PD-L1 and PD-1/CD80 and its overexpression on cancer cells.